Indian Journal of Pharmacology Home 

RESEARCH ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2015  |  Volume : 47  |  Issue : 2  |  Page : 153--159

Differential effects of dexamethasone and rosiglitazone in a sephadex-induced model of lung inflammation in rats: Possible role of tissue inhibitor of metalloproteinase-3

Jignesh K Nagar1, Praful P Patel2, Jogeswar N Mohapatra3, Manoranjan M Sharma3, Gaurav M Pandya4, Malik M Umar3, Abhijit A Chatterjee3, Shrikalp S Deshpande6, Mukul R Jain3, Hitesh M Soni5 
1 Department of Pharmacology, Zydus Research Centre, Ahmedabad; Department of Pharmacology, KB Institute of Pharmaceutical Education and Research, Gandhinagar, Gujarat, India
2 Department of Toxicology, Torrent Research Center, Ahmedabad, Gujarat, India
3 Department of Pharmacology, Zydus Research Centre, Ahmedabad, Gujarat, India
4 Department of Animal Genetics and Breeding, College of Veterinary Science and Animal Husbandry, Navsari Agricultural University, Navsari, Gujarat, India
5 Department of Pharmacology, Zydus Research Centre, Ahmedabad, Gujarat, India; Department of Physiology, University of Tennessee Health Science Center, Memphis, TN, USA

Correspondence Address:
Hitesh M Soni
Department of Pharmacology, Zydus Research Centre, Ahmedabad, Gujarat, India; Department of Physiology, University of Tennessee Health Science Center, Memphis, TN, USA

Objectives: To study the effects of two different classes of drugs in sephadex-induced lung inflammation using rats and explore the potential mechanism (s). Materials and Methods: Effects of dexamethasone (0.3 mg/kg, p.o.) and rosiglitazone (10 mg/kg, p.o.) treatments were evaluated up to 3 days in sephadex challenged rats. 72 h postsephadex administration, broncho-alveolar lavage fluid (BALF) was collected for cell count and cytokine estimation. Lung tissues were harvested for gene expression and histopathology. Results: Dexamethasone treatment resulted in significant inhibition of lymphocytes, monocytes, eosinophils and neutrophils, whereas rosiglitazone inhibited eosinophils and neutrophils only. Further, dexamethasone reduced the elevated levels of prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) after sephadex challenge while rosiglitazone significantly reduced the PGE2 levels without altering LTB4 in the BALF. Hydroxyproline content in rat lung homogenate was significantly reduced with dexamethasone treatment but not with rosiglitazone. Both the drugs were found to suppress matrix metallo proteinase 9, whereas only dexamethasone showed inhibition of tumor necrosis factor-alpha and up-regulation of tissue inhibitor of metalloproteinase 3 (TIMP-3) expression and preserved the broncho-alveolar microstructure. Conclusions: Our results revealed that up-regulation of TIMP-3 corroborated well with dexamethasone mediated inhibition of collagen degradation and restoration of alveolar micro-architecture.


How to cite this article:
Nagar JK, Patel PP, Mohapatra JN, Sharma MM, Pandya GM, Umar MM, Chatterjee AA, Deshpande SS, Jain MR, Soni HM. Differential effects of dexamethasone and rosiglitazone in a sephadex-induced model of lung inflammation in rats: Possible role of tissue inhibitor of metalloproteinase-3.Indian J Pharmacol 2015;47:153-159


How to cite this URL:
Nagar JK, Patel PP, Mohapatra JN, Sharma MM, Pandya GM, Umar MM, Chatterjee AA, Deshpande SS, Jain MR, Soni HM. Differential effects of dexamethasone and rosiglitazone in a sephadex-induced model of lung inflammation in rats: Possible role of tissue inhibitor of metalloproteinase-3. Indian J Pharmacol [serial online] 2015 [cited 2021 Mar 2 ];47:153-159
Available from: https://www.ijp-online.com/article.asp?issn=0253-7613;year=2015;volume=47;issue=2;spage=153;epage=159;aulast=Nagar;type=0